Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-01-22 4:18 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 17,235,590 21.6% | 5,078,217 (+41.77%) | View |
| 2021-01-08 5:00 pm Sale | 13D | ONCOCYTE CORPORATION OCX | Lineage Cell Therapeutics Inc. LCTX | 3,297,401 4.9% | -968,503 (-22.70%) | View |
| 2020-04-27 5:28 pm Sale | 13D | ONCOCYTE CORPORATION OCX | Lineage Cell Therapeutics Inc. LCTX | 4,265,904 6.3% | -1,775,250 (-29.39%) | View |
| 2020-02-14 12:14 pm Purchase | 13G | ONCOCYTE CORPORATION OCX | PURA VIDA INVESTMENTS LLC | 5,696,576 9.41% | 2,755,400 (+93.68%) | View |
| 2020-01-06 5:00 pm Sale | 13D | ONCOCYTE CORPORATION OCX | Lineage Cell Therapeutics Inc. LCTX | 6,041,154 10% | -2,383,090 (-28.29%) | View |
| 2019-11-22 11:43 am Purchase | 13G | ONCOCYTE CORPORATION OCX | PURA VIDA INVESTMENTS LLC | 2,941,176 5.16% | 2,941,176 (New Position) | View |
| 2019-09-13 5:18 pm Sale | 13D | ONCOCYTE CORPORATION OCX | Lineage Cell Therapeutics Inc. LCTX | 8,424,244 16.2% | -4,000,000 (-32.20%) | View |
| 2019-09-13 5:08 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 12,157,373 22.9% | 2,000,000 (+19.69%) | View |
| 2019-07-05 4:30 pm Sale | 13D | ONCOCYTE CORPORATION OCX | Lineage Cell Therapeutics Inc. LCTX | 12,424,244 23.9% | -2,250,000 (-15.33%) | View |
| 2019-07-02 5:09 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 10,157,373 19.2% | 1,000,000 (+10.92%) | View |
| 2019-05-22 07:54 am Purchase | 13G | ONCOCYTE CORPORATION OCX | KARFUNKEL GEORGE | 5,120,000 9.5% | 5,120,000 (New Position) | View |